Citations to this article

Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes.
D A Fetchick, … , G R Mundy, J F Dunn
D A Fetchick, … , G R Mundy, J F Dunn
Published August 1, 1986
Citation Information: J Clin Invest. 1986;78(2):592-596. https://doi.org/10.1172/JCI112614.
View: Text | PDF
Research Article

Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes.

Abstract

The human T cell lymphotrophic virus type I (HTLV-I) has recently been identified in a T cell lymphoma associated with hypercalcemia and increased bone turnover. Since increased serum concentrations of 1,25-dihydroxyvitamin D have been reported in this disease, we have examined the capacity of HTLV-I-infected cord blood lymphocytes to metabolize 25-hydroxyvitamin D3. Our results demonstrate that HTLV-I-infected cells have the capacity to metabolize 25-hydroxyvitamin D3 to a substance that co-migrates with 1,25-dihydroxyvitamin D3 by high performance liquid chromatography over a silica column using either 12% isopropanol in hexane or 5% isopropanol in dichloromethane. The metabolite binds to the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells and stimulates bone resorption in cultures of fetal rat long bones. Mass spectrometric analysis of the metabolite confirmed the presence of 1,25-dihydroxyvitamin D3. Production of 1,25-dihydroxyvitamin D by lymphoma cells may contribute to the pathogenesis of the hypercalcemia seen in patients with HTLV-I-associated T cell lymphomas.

Authors

D A Fetchick, D R Bertolini, P S Sarin, S T Weintraub, G R Mundy, J F Dunn

×

Total citations by year

Year: 2019 2017 2015 2011 2009 2008 2007 2006 2005 2000 1999 1998 1997 1996 1994 1993 1992 1991 1990 1989 1988 1987 1985 1984 Total
Citations: 2 1 2 2 1 1 1 1 3 1 2 5 2 1 2 4 4 4 6 5 8 7 1 1 67
Citation information

Citations to this article (67)

Title and authors Publication Year
Lung tumor cells inhibit bone mineralization and osteoblast activity
TE Berent, JM Dorschner, TA Craig, MT Drake, JJ Westendorf, R Kumar 		Biochemical and Biophysical Research Communications 2019
Vitamin D and HTLV Infection: A Systematic Review
E Netto, M Gomes-Neto, C Brites 		The Open Infectious Diseases Journal 2019
Mechanisms of Hypercalcemia in non-Hodgkin Lymphoma and Associated Outcomes: a Retrospective Review
RM Shallis, RS Rome, JL Reagan 		Clinical Lymphoma, Myeloma & Leukemia 2017
Liquid Chromatography-Mass Spectrometry Metabolic and Lipidomic Sample Preparation Workflow for Suspension-Cultured Mammalian Cells using Jurkat T lymphocyte Cells
CZ Ulmer 		Journal of proteomics & bioinformatics 2015
Manifestaciones osteoarticulares de las hemopatías malignas (excluido el mieloma)
S Roux 		EMC - Aparato Locomotor 2015
Hypercalcemia Due to Vitamin D Toxicity
NE Cusano, S Thys-Jacobs, JP Bilezikian 		Vitamin D 2011
Mechanisms and treatment of hypercalcemia of malignancy:
GA Clines 		Current opinion in endocrinology, diabetes, and obesity 2011
Bone Metastases
D Kardamakis, V Vassiliou, E Chow 		2009
Critical Care Medicine
SS Braithwaite 		Critical Care Medicine 2008
HTLV-1-Associated Adult T Cell Leukemia Lymphoma Presenting as Granulomatous Pneumocystis Jiroveci Pneumonia (PJP) and Hypercalcemia
S Shahnaz, D Reich, D Arévalo-Valencia, S Kucinska, J Tulczynska, J Fleischman 		Journal of General Internal Medicine 2007
Manifestations ostéoarticulaires des hémopathies malignes (myélome exclu)
S Roux, X Mariette 		EMC - Appareil locomoteur 2006
ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals
M Saito, N Eiraku, K Usuku, Y Nobuhara, W Matsumoto, D Kodama, AH Sabouri, S Izumo, K Arimura, M Osame 		Journal of the Neurological Sciences 2005
Manifestaciones osteoarticulares de las hemopatías malignas (excepto el mieloma)
S Roux, X Mariette 		EMC - Aparato Locomotor 2005
Bone Resorption
F Bronner, MC Farach-Carson, J Rubin 		2005
Hémopathies malignes et os (myélome exclu)
S Roux, X Mariette 		Revue du Rhumatisme 2000
A patient with acute lymphoblastic leukemia who presented with osteoporosis and vertebral fractures
A Panteli, N Pritsivelis, S Tsiara, G Vartholomatos, KL Bourantas 		European Journal of Haematology 1999
Hypercalcemia Complicating Leukemic Transformation of Agnogenic Myeloid Metaplasia-Myelofibrosis
S Kumar, BM Mow, SH Kaufmann 		Mayo Clinic Proceedings 1999
Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes
CLAVREUL, D'HELLENCOURT, MONTERO-MENEI, POTRON, COUEZ 		Immunology 1998
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane 		Metabolic Bone Disease and Clinically Related Disorders 1998
Parathyroid Hormone-Related Protein in Hypercalcemia Associated with Hematological Malignancy
F Firkin, H Schneider, V Grill 		Leukemia & Lymphoma 1998
Cancer and Bone*
TA Guise, GR Mundy 		Endocrine reviews 1998
Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.
Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D 		Immunology 1998
Mechanisms of bone lesions in multiple myeloma and lymphoma
GD Roodman 		Cancer 1997
Differential diagnosis, causes, and management of hypercalcemia
FK Chan, LM Koberle, S Thys-Jacobs, JP Bilezikian 		Current Problems in Surgery 1997
Combination of Vitamin D Analogues and Immunosuppressants: Potential Clinical Use
DD Branisteanu, C Mathieu, K Casteels, R Bouillon 		Clinical immunotherapeutics 1996
Hypercalcaemia in B cell chronic lymphocytic leukaemia
O Fain, AE M'Selmi, C Dosquet, D Meseure, F Lejeune, JM Garel, M Thomas 		British Journal of Haematology 1994
Lymphomatous Presentation of CD4+/CD8+ HTLV-1-Related Adult T-cell Leukemia/Lymphoma in an Iranian Woman
JF Seymour, A Younes, F Cabanillas 		Leukemia & Lymphoma 1994
1,25-Dihydroxyvitamin D3 Exerts Opposing Effects to IL-4 on MHC Class-II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes
H Xu, A Soruri, RK Gieseler, JH Peters 		Scandinavian Journal of Immunology 1993
Lower affinity for substrate for extrarenal synthesis of calcitriol in chronic uremia
L Negrea, E Slatopolsky, A Dusso 		Kidney International 1993
Surgical Endocrinology
M Press 		Surgical Endocrinology 1993
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin 		1993
Calcium and vitamin D metabolism in granulomatous diseases
M Fuss, T Pepersack, C Gillet, R Karmali, J Corvilain 		Clinical Rheumatology 1992
1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes
N Tokuda, N Mizuki, M Kasahara, RB Levy 		Immunology 1992
Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphoma
SR Johnston, PJ Hammond 		Postgraduate medical journal 1992
8 Management of disorders of calcium homoeostasis
R Rizzoli, JP Bonjour 		Baillière's Clinical Endocrinology and Metabolism 1992
Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment
L Mosekilde, EF Eriksen, P Charles 		Critical Reviews in Oncology/Hematology 1991
Recent advances in the molecular mechanism of action of 1, 25-dihydroxyvitamin D3
HF DeLuca 		Journal of Bone and Mineral Metabolism 1991
Case Report: Hypercalcemia with Excess Serum 1,25 Dihydroxyvitamin D in Lymphomatoid Granulomatosis/Angiocentric Lymphoma
SJ Scheinman, MW Kelberman, AH Tatum, KW Zamkoff 		The American Journal of the Medical Sciences 1991
Ectopic Production of Calciotropic Peptides
GR Mundy 		Endocrinology and metabolism clinics of North America 1991
1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis
J Cadranel, M Garabedian, B Milleron, H Guillozo, G Akoun, AJ Hance 		Journal of Clinical Investigation 1990
Incidence and pathophysiology of hypercalcemia
GR Mundy 		Calcified Tissue International 1990
Hypercalcemia and vitamin d metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?
JW Rieke, SS Donaldson, SJ Horning 		Cancer 1990
Immune system and bone remodeling
GR Mundy 		Trends in Endocrinology & Metabolism 1990
Bone and Mineral Research
A Perault-Staub, J Staub, G Milhaud 		Bone and Mineral Research 1990
Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease
R Karmali, S Barker, M Hewison, L Fraher, DR Katz, JL O'Riordan 		Postgraduate medical journal 1990
The role of the vitamin D endocrine system in health and disease
S Christakos, M Raval-Pandya, RP Wernyj, W Yang 		New England Journal of Medicine 1989
Proceedings of the 1988 Laurentian Hormone Conference
T Martin, E Allan, I Caple, A Zare, J Danks, H Diefenbach-Jagger, P Ebeling, M Zillespie, G Hammonds, J Heath, P Hudson, B Kemp, M Kubota, S Kukreja, J Moseley, K Ng, L Raisz, C Rodda, H Simmons, L Suva, R Wettenhal, W Wood 		Proceedings of the 1988 Laurentian Hormone Conference 1989
Recent Advances in Pathophysiology and Treatment of Hypercalcemia of Malignancy
GR Mundy, AJ Yates 		American Journal of Kidney Diseases 1989
Review article : Hypercalcaemia of malignancy
DA Heath 		Palliative Medicine 1989
Hypercalcaemia of malignancy
PJ Kelly, JA Eisman 		Cancer and Metastasis Reviews 1989
Hypercalcemia of malignancy revisited
GR Mundy 		Journal of Clinical Investigation 1988
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris 		Vitamin D 1988
Vitamin D Metabolite Production and Function in Keratinocytes
DD Bikle, S Pillai 		Annals of the New York Academy of Sciences 1988
The immunobiology ofvitamin D
RW Baldwin 		Immunology Today 1988
Recurrent hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in hodgkin's disease
RJ Mercier, JM Thompson, GS Harman, GL Messerschmidt 		The American Journal of Medicine 1988
Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type I-infected T cell line
T Motokura, S Fukumoto, S Takahashi, T Watanabe, T Matsumoto, T Igarashi, E Ogata 		Biochemical and Biophysical Research Communications 1988
Lymphocytic Population and Vitamin D
P Fauquert, P Youinou, PL Goff 		International journal of immunopathology and pharmacology 1988
Current Management of Malignant Hypercalcaemia:
JC Stevenson 		Drugs 1988
Vitamin D and the kidney
MF Holick 		Kidney International 1987
The hypercalcemia of malignancy
GR Mundy 		Kidney International 1987
Overview of human cells in genetic research: Altered phenotypes in human cells caused by transferred genes
DE Brash, GE Mark, MP Farrell, CC Harris 		Somatic Cell and Molecular Genetics 1987
1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation
WC Chen, B Vayuvegula, S Gupta 		Clinical & Experimental Immunology 1987
Rationale for diphosphonate therapy in hypercalcemia of malignancy
RE Canfield 		The American Journal of Medicine 1987
Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
IR Garrett, BG Durie, GE Nedwin, A Gillespie, T Bringman, M Sabatini, DR Bertolini, GR Mundy 		New England Journal of Medicine 1987
Hormone Resistance and Other Endocrine Paradoxes
MP Cohen, PP Foà 		1987
Progress in Medicinal Chemistry
JR Brown, SH Imam 		Progress in Medicinal Chemistry 1985
Mass spectrometry
AL Burlingame, JO Whitney, DH Russell 		Analytical Chemistry 1984

Advertisement